UK Women Face Shortages of Hormone Replacement Therapy Patches

Published 21h ago · Latest report 2h ago · Health crisis

Affects United Kingdom

AI summary40s readNegative

UK women face ongoing shortages of popular hormone replacement therapy patches.

Women across the UK are experiencing supply disruptions for certain hormone replacement therapy patches, including Estradot and FemSeven Conti brands. Medical professionals advise patients seeking alternative treatments to ensure they match their existing oestrogen dosage and delivery method. Regulatory bodies and manufacturers have warned that these shortages may continue for several weeks.

Expert adviceDoctors recommend switching only to alternatives that provide an equivalent oestrogen dose through the same method.
Timeline warningHealth specialists indicate that the distribution disruptions could last for multiple weeks.

Why it matters

Hormone replacement therapy is a vital medical treatment used by many women to manage menopausal symptoms, making reliable access to specific dosages essential for daily health and well-being. Supply chain disruptions for these medications frequently cause anxiety and force patients to navigate complex medication switches under medical guidance.

Timeline2

Oct 14Warnings are issued regarding supply shortages affecting specific hormone replacement therapy patches.
Oct 15Experts advise patients to seek alternative treatments delivering identical oestrogen doses by the same method.

How outlets cover it

What outlets agree on

Women in the United Kingdom are experiencing shortages of specific hormone replacement therapy patches, prompting warnings that supply issues will persist for weeks.

Tune your feed

Reactions